RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 73-84
  • Expectations affect benefits of pain drug

    Expectations affect benefits of pain drug
    People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report. Researchers from Britain and Germany used brain scans...
  • Doctor-drug company database adds to confusion for consumers

    Doctor-drug company database adds to confusion for consumers
    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues. He found several doctors who had potentially compromising...
  • Two day hearing to decide fate of Diabetes pill

    Two day hearing to decide fate of Diabetes pill
    Hearings begin today on whether the drug Avandia should stay on the market. Ahead of the hearings, FDA scientists have blasted a study by drug maker GlaxoSmithKline used to defend the safety of the once high-riding diabetes drug, which fell out of favor...
  • Glaxo Settles Avandia Lawsuits for $460 Million

    Glaxo Settles Avandia Lawsuits for $460 Million
    GlaxoSmithKline agreed to pay about $460 million to resolve a majority of lawsuits alleging the company's Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said. Glaxo, the U.K.'s biggest drugmaker, agreed to...
  • The Avandia Dilemma

    The Avandia Dilemma
    The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...
  • For Diabetes Drug Avandia, Bad News Continues

    For Diabetes Drug Avandia, Bad News Continues
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....
  • Experts Vote to Keep Avandia

    Experts Vote to Keep Avandia
    U.S. health advisers said GlaxoSmithKline Plc's GSK.L diabetes drug Avandia should be allowed to stay on the market in some form, easing a threat of further litigation that could have followed a ban. The 33-member panel of outside experts convened by the...
  • FDA: Avandia Should Stay With Restrictions

    FDA: Avandia Should Stay With Restrictions
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
  • Looking beyond Avandia for diabetes treatment

    Looking beyond Avandia for diabetes treatment
    The safety of most diabetes drugs are time-tested — insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s. Avandia is different. The drug landed with a...
  • Jailed Psychiatrist Pleads Guilty

    Jailed Psychiatrist Pleads Guilty
    Sentenced On Charges Of Falsified Records Of Clinical Trials Involving Children. DR. MARIA CARMEN PALAZZO, age 58, pled guilty in federal court today before U. S. District Judge Mary Ann Vial Lemmon to fifteen (15) counts of failing to prepare and...
  • Glaxo adds safety restrictions to Avandia label

    Glaxo adds safety restrictions to Avandia label
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
  • Gates Foundation to improve child vaccines in China

    Gates Foundation to improve child vaccines in China
    The Bill and Melinda Gates Foundation is helping partners in China improve child vaccines, roll out faster TB detection kits and make higher-yielding rice which it hopes can be used later in other parts of the world. Ray Yip, the foundation's chief...